Impact of the Therapeutic Education Program "living with a Chronic Inflammatory Disease Under Biotherapy" on Patient Compliance and Quality of Life
Impact of the Therapeutic Education Program "living with Chronic Inflammatory Disease Under Biotherapy" on Compliance and Quality of Life of Patients
Groupe Hospitalier de Bretagne Sud
126 participants
Feb 14, 2025
OBSERVATIONAL
Conditions
Summary
Patient therapeutic education programs have been shown to be effective in many specialties, allowing "Improving biological and psychological parameters, allowing patients to improve their health knowledge, therapeutic adherence and sense of personal effectiveness." Several studies have shown that patient knowledge, adherence and satisfaction are better after attending a therapeutic education program. This multidisciplinary program is presented and offered to all patients with chronic disease treated by subcutaneous biotherapy, followed by dermatologists, rheumatologists and gastroenterologists of the Lorient hospital. The study aims to demonstrate the benefit of the Patient Therapeutic Education program at GHBS Lorient "living with a chronic inflammatory disease under biotherapy" on treatment adherence, as well as the positive impact on quality of life.
Eligibility
Inclusion Criteria3
- All major patients followed up on GHBS for chronic inflammatory disease treated with S/C biotherapy.
- Patients not opposed to their participation in the research.
- Less than 3 months between inclusion and start of Therapeutic Education Program.
Exclusion Criteria5
- Subcutaneous injection by another person.
- Patients with cognitive impairment.
- Persons of legal age who are the subject of a legal protection (safeguarding of justice, curatorship, guardianship), persons deprived of liberty.
- Pregnant women.
- Persons not covered by social security.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Morisky and SF12 Questionnaires delivery at inclusion, 6, 12 and 18 months
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06620770